[Silica causes difficulties].

La silice cause des difficultés.
Granulomatose Granulomatosis Maladies professionnelles Professional illnesses Sarcoidosis Sarcoïdose Silica Silice Silicose Silicosis

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 27 11 2020
accepted: 25 03 2021
pubmed: 24 5 2021
medline: 18 9 2021
entrez: 23 5 2021
Statut: ppublish

Résumé

Silicosis and sarcoidosis are two very distinct entities in the literature. All the additional non-invasive examinations, including the chest CT scan, often do not differentiate them. The history, including occupational exposure to identified silica particles, is a discriminating factor. However, due to the pathogenic power of silica, it would be possible to have the simultaneous development of these two pathologies in the same patient. To illustrate this situation, here is the case of a 62-year-old patient, who presented initially with a picture of dyspnea and productive cough. The chest CT showed micronodular peribronchovascular infiltrates and mediastinal lymphadenopathy. The other additional examinations did not find anything specific. In the diagnostic process, the patient had multiple endoscopic samples which did not make it possible to be conclusive on one or the other of these pathologies. He therefore underwent a surgical lung biopsy which revealed histological lesions compatible with the two pathologies. Recent studies suggest that inhaled particles, especially silica, could be responsible for the pattern of sarcoidosis. However, it is difficult to say whether, in this case, silica was responsible for the development of sarcoidosis.

Identifiants

pubmed: 34023191
pii: S0761-8425(21)00237-0
doi: 10.1016/j.rmr.2021.05.001
pii:
doi:

Substances chimiques

Silicon Dioxide 7631-86-9

Types de publication

Case Reports Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

768-772

Informations de copyright

Copyright © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

S Pointel (S)

Pneumologie et oncologie thoracique, CHU de Saint Etienne, Saint Etienne, France.

P Gay (P)

Pneumologie et oncologie thoracique, CHU de Saint Etienne, Saint Etienne, France; Service de pneumologie, CHU Saint-Étienne, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France. Electronic address: pierre.gay42@gmail.com.

F Forest (F)

Anatomie et cytologie pathologique, CHU de Saint-Étienne, France.

O Tiffet (O)

Chirugie générale et thoracique, CHU Saint-Étienne, France.

T Trouillon (T)

Pneumologie et oncologie thoracique, CHU de Saint Etienne, Saint Etienne, France; Pneumologie et oncologie thoracique, CHU Saint-Étienne, Saint-Étienne, France.

M Froudarakis (M)

Pneumologie et oncologie thoracique, CHU de Saint Etienne, Saint Etienne, France; Pneumologie et oncologie thoracique, CHU Saint-Étienne, Saint-Étienne, France.

J-M Vergnon (JM)

Pneumologie et oncologie thoracique, CHU de Saint Etienne, Saint Etienne, France; Pneumologie et oncologie thoracique, CHU Saint-Étienne, Saint-Étienne, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH